Reginald F. Frye

Effect of St John's wort on imatinib mesylate pharmacokinetics

Reginald F. Frye, Sara M. Fitzgerald, Theodore Lagattuta et al. · Clinical Pharmacology & Therapeutics · 2004 · 255 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Liver disease selectively modulates cytochrome P450–mediated metabolism

Reginald F. Frye, N ZGHEIB, Gary R. Matzke et al. · Clinical Pharmacology & Therapeutics · 2006 · 246 citations

Medicine, Pharmacology, Biochemical Pharmacology +16

Validation of the five-drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug-metabolizing enzymes*

Reginald F. Frye, Gary R. Matzke, Adedayo Adedoyin et al. · Clinical Pharmacology & Therapeutics · 1997 · 241 citations

Medicine, Pharmacokinetics, Pharmacology +14

INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN’S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES

Bernard J. Komoroski, Shimin Zhang, Hongbo Cai et al. · Drug Metabolism and Disposition · 2004 · 180 citations

Medicine, Biochemistry, Pharmacology +17

Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects

MyPhuong T. Le, Reginald F. Frye, Christopher J. Rivard et al. · Metabolism · 2011 · 165 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacokinetics +14